RESPIRATORY INFECTION

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

A J White, S Gompertz, D L Bayley, S L Hill, C O’Brien, I Unsal, R A Stockley

Department of Respiratory Medicine, Queen Elizabeth Hospital, Birmingham B15 2TH, UK

Correspondence to:
Correspondence to:
Professor R A Stockley, Department of Respiratory Medicine, First Floor Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK;
r.a.stockley{at}bham.ac.uk

Background: Recent studies of the role of bacteria in chronic bronchitis have shown that bacterial colonisation is associated with enhanced inflammation and that purulent acute exacerbations of chronic bronchitis (AECB) are associated with bacteria and characterised by increased inflammation. Changes in bronchial inflammation in response to the success or failure of bacterial eradication following AECB were therefore studied.

Methods: Bacterial quantitative culture and sputum markers of inflammation (myeloperoxidase (MPO), neutrophil elastase, leukotriene B4 (LTB4), sol:serum albumin ratio, and secretory leukoprotease inhibitor) were measured in patients presenting with culture positive purulent AECB and repeated 10 days and 2 months later. 41 patients provided sputum sufficient for both bacteriology and assessment of inflammation at baseline and day 10, and 46 provided sufficient sample for bacteriology, 40 of which could also be analysed for inflammation at 2 months (when clinically stable).

Results: At day 10, 17 of the 41 patient samples had a positive bacterial culture. In the stable state, 18 of the 46 samples had a positive culture, but with a significantly lower bacterial load than at presentation. Although there was no difference between the groups at presentation, the concentration of MPO was lower (p<0.05) in those in whom bacteria were eradicated by day 10 than in those with persisting bacteria. The LTB4 concentration was similarly lower (p<0.001) in those in whom bacteria were eradicated than in those with persistent bacteria. In the stable clinical state the concentrations of both MPO and LTB4 were lower in those in whom bacteria were eradicated than in patients with persisting bacteria.

Conclusion: Resolution of bronchial inflammation following AECB is related to bacterial eradication. Those in whom bacteria continue to be cultured in their sputum have partial resolution of inflammation which may reflect continued stimulation by the reduced bacterial load.

Keywords: chronic bronchitis; bronchial inflammation; bacterial infection

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Miravitlles, M., Marin, A., Monso, E., Vila, S., de la Roza, C., Hervas, R., Esquinas, C., Garcia, M., Millares, L., Morera, J., Torres, A. (2009). Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. Eur Respir J 34: 1066-1071 [Abstract] [Full Text]  
• Zurak, K., Vagic, D., Drvis, P., Prohaska Potocnik, C., Dzidic, S., Kalogjera, L. (2009). Bacterial colonization and granulocyte activation in chronic maxillary sinusitis in asthmatics and non-asthmatics. J Med Microbiol 58: 1231-1235 [Abstract] [Full Text]  
• Janssens, W., Lehouck, A., Carremans, C., Bouillon, R., Mathieu, C., Decramer, M. (2009). Vitamin D Beyond Bones in Chronic Obstructive Pulmonary Disease: Time to Act. Am. J. Respir. Crit. Care Med. 179: 630-636 [Abstract] [Full Text]  
• Hurst, J. R., Donaldson, G. C., Quint, J. K., Goldring, J. J. P., Baghai-Ravary, R., Wedzicha, J. A. (2009). Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 179: 369-374 [Abstract] [Full Text]  
• Sethi, S., Murphy, T. F. (2008). Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease. NEJM 359: 2355-2365 [Full Text]  
• Wedzicha, J. A (2008). Antibiotics at COPD exacerbations: the debate continues. Thorax 63: 940-942 [Full Text]  
• Murphy, T. F., Brauer, A. L., Eschberger, K., Lobbins, P., Grove, L., Cai, X., Sethi, S. (2008). Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 177: 853-860 [Abstract] [Full Text]  
• Sethi, S., Wrona, C., Eschberger, K., Lobbins, P., Cai, X., Murphy, T. F. (2008). Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 177: 491-497 [Abstract] [Full Text]  
• Wouters, E. F. M., Groenewegen, K. H., Dentener, M. A., Vernooy, J. H. J. (2007). Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations. Proc Am Thorac Soc 4: 626-634 [Abstract] [Full Text]  
• Martinez, F. J. (2007). Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 647-658 [Abstract] [Full Text]  
• Miravitlles, M. (2007). Review: Do we need new antibiotics for treating exacerbations of COPD?. Ther Adv Respir Dis 1: 61-76 [Abstract]  
• Anzueto, A., Sethi, S., Martinez, F. J. (2007). Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 554-564 [Abstract] [Full Text]  
• Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., Zielinski, J. (2007). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am. J. Respir. Crit. Care Med. 176: 532-555 [Abstract] [Full Text]  
• Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., Johnston, S. L. (2006). Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. Am. J. Respir. Crit. Care Med. 173: 1114-1121 [Abstract] [Full Text]  
• Wedzicha, J. A., Wilkinson, T. (2006). Impact of Chronic Obstructive Pulmonary Disease Exacerbations on Patients and Payers. Proc Am Thorac Soc 3: 218-221 [Abstract] [Full Text]  
• Papi, A., Luppi, F., Franco, F., Fabbri, L. M. (2006). Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 3: 245-251 [Abstract] [Full Text]  
• O'Donnell, R, Breen, D, Wilson, S, Djukanovic, R (2006). Inflammatory cells in the airways in COPD. Thorax 61: 448-454 [Abstract] [Full Text]  
• Wilson, R, Jones, P, Schaberg, T, Arvis, P, Duprat-Lomon, I, Sagnier, P P, for the MOSAIC Study Group, (2006). Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax 61: 337-342 [Abstract] [Full Text]  
• Sapey, E, Stockley, R A (2006). COPD exacerbations {middle dot} 2: Aetiology.. Thorax 61: 250-258 [Abstract] [Full Text]  
• Murphy, T. F., Brauer, A. L., Aebi, C., Sethi, S. (2005). Antigenic Specificity of the Mucosal Antibody Response to Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease. Infect. Immun. 73: 8161-8166 [Abstract] [Full Text]  
• Wilson, R. (2005). Treatment of COPD exacerbations: antibiotics. ERR 14: 32-38 [Abstract] [Full Text]  
• Belda, J., Cavalcanti, M., Ferrer, M., Serra, M., Puig de la Bellacasa, J., Canalis, E., Torres, A. (2005). Bronchial Colonization and Postoperative Respiratory Infections in Patients Undergoing Lung Cancer Surgery. Chest 128: 1571-1579 [Abstract] [Full Text]  
• Wilson, R. (2005). Bacteria and Airway Inflammation in Chronic Obstructive Pulmonary Disease: More Evidence. Am. J. Respir. Crit. Care Med. 172: 147-148 [Full Text]  
• Martinez, F. J., Grossman, R. F., Zadeikis, N., Fisher, A. C., Walker, K., Ambruzs, M. E., Tennenberg, A. M. (2005). Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg. Eur Respir J 25: 1001-1010 [Abstract] [Full Text]  
• Chodosh, S. (2005). Clinical Significance of the Infection-FreeInterval in the Management of Acute Bacterial Exacerbations of Chronic Bronchitis. Chest 127: 2231-2236 [Abstract] [Full Text]  
• Miravitlles, M., Torres, A. (2004). Antibiotics in exacerbations of COPD: lessons from the past. Eur Respir J 24: 896-897 [Full Text]